Navigation Links
Adamis Pharmaceuticals CEO Provides Update for Shareholders
Date:5/3/2013

SAN DIEGO, May 3, 2013 /PRNewswire/ -- Dennis J. Carlo, Ph.D., the President and Chief Executive Officer of Adamis Pharmaceuticals Corporation (OTCQB: ADMP), a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology and immunology, today provided the following letter to shareholders:

Dear Shareholder:

A number of stockholders have been asking me to comment on our developments; therefore I thought it might be appropriate to put my response in a letter to all of our shareholders.  We have been relatively quiet this past year, but at the same time, we have been busy trying to build our Company.  Results will speak for themselves, and we certainly have our challenges and obviously there are no assurances, but I am extremely excited and optimistic about our future.  Creating and developing the assets that we currently have has taken a considerable amount of time, dedication, effort and a "never give-up" attitude.  Having put many of the pieces of the puzzle together, I believe that we are poised to embark on a journey that will transform Adamis and could propel us to new levels.

We are laying the foundation to support a company that we believe has the potential to generate significant revenues, profits and shareholder value.  In both the specialty pharmaceutical and biotechnology areas, we have a platform technology, a clear business and financial model, an experienced management team, significant intellectual property, and very large (in some cases, billion dollar) potential markets for our product candidates.

This year our current objectives include:

  • Focusing on submitting our single dose epinephrine syringe for regulatory approval and sale next year
  • Completing the manufacture of o
    '/>"/>

SOURCE Adamis Pharmaceuticals Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results
2. Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
3. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
4. Aurigenes Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones
5. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
6. Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
7. Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017
8. US Radiopharmaceuticals (USR) Awards Contract to Von Gahlen International for New Technetium-99m Generator Production Line Using Low Enriched Uranium Molybdenum-99
9. Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
10. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2012 Financial Results
11. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. ... on gynecologic disease, announced today that the Company ... including Oracle Investment Management, Jack W. Schuler ... Total proceeds were $10.5 million, before offering expenses.  ... and general corporate purposes. Under the ...
(Date:12/24/2014)... Louis, Missouri (PRWEB) December 23, 2014 ... targeting Swiss biotechnology company, Syngenta, are in the process ... pretrial proceedings. The consolidated case is In Re: Syngenta ... the U.S. District Court for the District of Kansas. ... (MDL) has been handed over to U.S. District Judge ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 On ... law H.R. 83, the Omnibus and Continuing Resolution ... time, made hydrocephalus a condition eligible to receive ... (CDMRP) administered by the Department of Defense (DoD). ... its allies on Capitol Hill, is celebrating this ...
(Date:12/24/2014)... Nashville, Tenn. (PRWEB) December 23, 2014 ... Hill was elected treasurer for the American Society ... to advancing knowledge and research in reproductive medicine. ... fills a seat on the executive board and will ... , Dr. Hill has actively supported ASRM since ...
Breaking Biology Technology:Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3
... Berbee Information Networks Corp. caught IBM 's ... Cuyahoga Falls, Ohio, that allowed residents to conduct business with ... gave the Madison company its annual "Best IBM iSeries On ... on during peak periods to provide more capacity. , ,This ...
... the scale of September 11 or Hurricane Katrina, but ... to ensure the Badger State responds more like New ... Emergency Management Planning Project, conceived following September 11, was ... by WTN Media last week. Those in attendance included ...
... a Hollywood hit a mysterious drug company... money local heroes ... "leading lady" of sorts. , ,But it's not "The Constant ... this week for Rachel Weisz. Rather, it is the true-to-life ... largest pharmaceutical firms, is planting a flag in Wisconsin. , ...
Cached Biology Technology:State initiative prepares Wisconsin IT systems for a disaster 2State initiative prepares Wisconsin IT systems for a disaster 3Theres more than a bit of mystery, but attracting 'Big Pharma' is good for the state 2Theres more than a bit of mystery, but attracting 'Big Pharma' is good for the state 3
(Date:12/22/2014)... SHELTON, Conn. , Dec. 22, 2014  NXT-ID, ... or the "Company"), a biometric authentication company focused on ... famous pickpocket, entertainer and security consultant, Apollo Robbins ... Wocket™ biometric smart wallet.  Apollo ... 6th and 7 th , 2015, demonstrating some of ...
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal ... that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four ... has served as a meeting place for peoples ... and the ongoing mixing of peoples with African, European, ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data ... industry leaders such as Intel, Jabra, Atlas, and Scosche ... products. These products will be showcased at CES 2015, ... . "Our partners choose PerformTek ... – with the clinical data to back it up," ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 423andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... BEDFORD, Mass., Oct. 28, 2013  Aware, Inc. (NASDAQ: AWRE ... financial results for its third quarter ended September 30, 2013.  ... million, a decrease of 15% compared to $5.3 million in the ... of 2013 was $1.2 million, or $0.05 per diluted share, which ...
... The ability to shrink laboratory-scale processes to automated ... example, inexpensive and highly portable devices that process ... anthrax are needed by the U.S. military and ... of "lab-on-a-chip" technology is the need for miniaturized ...
... agriculture that began in the 1960s, potassium chloride (KCl), the ... as a major fertilizer in the Corn Belt without regard ... their fundamental importance to soil fertility. Three University of Illinois ... potassium management that has been in place for the past ...
Cached Biology News:Aware, Inc. Reports Third Quarter 2013 Financial Results 2Aware, Inc. Reports Third Quarter 2013 Financial Results 3Aware, Inc. Reports Third Quarter 2013 Financial Results 4Aware, Inc. Reports Third Quarter 2013 Financial Results 5Super-thin membranes clear the way for chip-sized pumps 2Study challenges soil testing for potassium and the fertilizer value of potassium chloride 2Study challenges soil testing for potassium and the fertilizer value of potassium chloride 3Study challenges soil testing for potassium and the fertilizer value of potassium chloride 4
Donor Goat Serum...
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
... monoclonal [APS 26] to Presenilin 2 ... form of the disease carry mutations in ... amyloid precursor protein (APP). These disease-linked mutations ... form of amyloid-beta (main component of amyloid ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.9 mg/dL to 200 mg/dL. Procedure: 2 min....
Biology Products: